December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Patients progressing on 1L palbo should not receive further exposure to palbo-  Paolo Tarantino
Jun 10, 2023, 02:53

Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino

Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in terms of PFS or OS with the use of palbociclib beyond progression to 1L ET+palbo. Patients progressing on 1L palbo should not receive further exposure to palbo. #ASCO23

Source: Paolo Tarantino/Twitter